Medical Crossfire on the Paradigm Shifts in Migraine Therapy: Jessica Ailani, MD

WATCH TIME: 5 minutes

“I will tell you that in headache medicine, I really struggled with telemedicine. I personally think there are a couple of benefits to it, but there are a lot of challenges that people don't talk about. The challenge of licensing in multiple states, [for example]. I think that many providers think you're just covered if you're licensed in 1 state and that's actually not true.”

Jessica Ailani, MD, director of the MedStar Georgetown University Hospital Headache Center, served as a cochair at the 2022 International Congress on the Future of Neurology (IFN) annual meeting, held September 23-24, in Manhattan, New York. She mentioned that one of the takeaways from the meeting was the discussion around telemedicine and other shifts in the paradigm of neurologic care.

As many of her patients are comorbid as well as taking newer treatment options, she tries to ensure her understanding of what they are taking and how those medicines could interact with one another. She also expressed her concern to educate herself on different treatments to improve the prognostic capabilities for each patient.

In a recent conversation with NeurologyLive^®, Ailani shared her takeaways from participating in a medical crossfire event at the IFN annual meeting with Stewart Tepper, MD, professor of neurology, Geisel School of Medicine, Darthmouth, on the topic of “Best Practices and Paradigm Changes for Acute and Prophylactic Therapy.” She also offered reflections from the event, including how the future is looking different as the use of treatments are changing.